Clinical trial

HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study

NCT00370526 · Stereotaxis, Industry · Terminated

Key facts

NCT number NCT00370526
Title HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study
Official title HEmodynamic Assessment of Optimal Left Heart Lead Placement for Heart Failure Enabled by Magnetic Navigation
Lead sponsor Stereotaxis, Industry
Collaborators Medtronic Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Heart Failure, Congestive
Intervention type Procedure
Interventions Acute hemodynamic assessment using PV Loops (CD Leycom, The Netherlands) during LV lead placement
Enrollment 100
Start date Feb 1, 2007
Primary completion Apr 1, 2007
Completion Dec 1, 2007
First posted Aug 31, 2006
Last update posted Jan 11, 2008
Countries Canada, Italy, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies